lobbying_activities: 1444230

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1444230	b84dbc4c-a7f0-4e19-81af-c93fcce8de24	Q3	RED+BLUE STRATEGIES	400693064	PEW CHARITABLE TRUSTS	2013	third_quarter	PHA	Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA. H.R. 3204 - The Drug Quality and Security Act - Legislation to address the security of the nation's pharmaceutical supply chain anddrug compounding practices. H.R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - Focused on funding for the FDA, CDC and other public health related industries.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2013-10-16T13:57:52.667000-04:00